Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Curcumin: getting back to the roots.

Shishir Shishodia1, Gautam Sethi, Bharat B Aggarwal

  • 1Cytokine Research Laboratory, Department of Experimental Therapeutics, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

Annals of the New York Academy of Sciences
|January 3, 2006
PubMed
Summary

Curcumin, the active compound in turmeric, targets numerous molecular pathways to treat various inflammatory diseases like cancer and arthritis. Its natural analog, 6-gingerol, shows similar benefits, highlighting the therapeutic potential of these plant-derived compounds.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Curcumin, inflammation, and neurological disorders: How are they linked?

Integrative medicine research·2023
Same author

Role of Turmeric and Curcumin in Prevention and Treatment of Chronic Diseases: Lessons Learned from Clinical Trials.

ACS pharmacology & translational science·2023
Same author

The International Natural Product Sciences Taskforce (INPST) and the power of Twitter networking exemplified through #INPST hashtag analysis.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2022
Same author

Multifunctionality of Calebin A in inflammation, chronic diseases and cancer.

Frontiers in oncology·2022
Same author

Multitargeting Effects of Calebin A on Malignancy of CRC Cells in Multicellular Tumor Microenvironment.

Frontiers in oncology·2021
Same author

Evidence That Tumor Microenvironment Initiates Epithelial-To-Mesenchymal Transition and Calebin A can Suppress it in Colorectal Cancer Cells.

Frontiers in pharmacology·2021

Area of Science:

  • Natural Product Chemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Turmeric (Curcuma longa) has a long history of use in traditional medicine for inflammatory conditions.
  • Curcumin, its active component, has been studied for its diverse biological activities.
  • 6-gingerol from ginger (Zingiber officinalis) is a natural analog with similar therapeutic potential.

Purpose of the Study:

  • To review the molecular mechanisms of curcumin's anti-inflammatory and therapeutic effects.
  • To highlight the broad range of diseases curcumin can potentially treat.
  • To emphasize the value of natural compounds like curcumin and 6-gingerol.

Main Methods:

  • Review of scientific literature on curcumin and 6-gingerol.
  • Analysis of curcumin's molecular targets, including transcription factors, enzymes, and cytokines.

Related Experiment Videos

  • Examination of clinical applications for various pathologies.

    • Main Results:

    • Curcumin modulates key molecular targets such as NF-kappaB, COX2, and TNF.
    • It shows therapeutic potential in treating cancer, arthritis, diabetes, cardiovascular diseases, and neurodegenerative disorders.
    • 6-gingerol exhibits a similar biological activity profile to curcumin.

    Conclusions:

    • Curcumin's efficacy, safety, and cost-effectiveness support its use in modern medicine.
    • Natural compounds like curcumin and its analogs offer promising therapeutic avenues.
    • Further research into plant-derived compounds is warranted for treating inflammatory diseases.